Company Filing History:
3 out of 521 
1 out of 1 Years Active: 2021-2023
Title: Innovations of Sheng-Nan Lo in Radiotherapy
Introduction
Sheng-Nan Lo is a prominent inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of radiotherapy, particularly in the diagnosis and treatment of prostate cancer. With a total of 4 patents, his work focuses on innovative methods and compounds that enhance cancer treatment efficacy.
Latest Patents
One of Sheng-Nan Lo's latest patents is centered around PSMA targeted radiotherapy medicine and its preparation method. This invention introduces a novel precursor for radioisotope labeling with ligands that specifically bind to prostate-specific membrane antigen (PSMA). This advancement is crucial for both the diagnosis and treatment of prostate cancer. The pharmacophore of a PSMA inhibitor is composed of three molecules: glutamic acid, urea, and lysine. These components are linked by three variable linkers based on the pharmacological activity of the PSMA inhibitor. This allows for labeling with radioactive nuclei such as Ga-67, Ga-68, In-111, Lu-177, Cu-64, or Y-90 through a chelating agent. This innovation serves as a PSMA-targeted radioligand therapy for prostate cancer diseases, facilitating imaging analysis of human tumor models.
Another significant patent involves a compound targeting fibroblast activation protein, along with its preparation methods and uses. This disclosure relates to a compound represented by the formula (I) D-R1-R2-A-R' or its salt, emphasizing its preparation methods and applications in medical treatments.
Career Highlights
Sheng-Nan Lo has worked with esteemed organizations such as the Institute of Nuclear Energy Research under the Atomic Energy Council and the National Atomic Research Institute. His experience in these institutions has greatly contributed to his expertise in nuclear energy and radiotherapy.
Collaborations
Throughout his career, Sheng-Nan Lo has collaborated with notable colleagues, including Shih-Ying Lee and Su-Jung Chen. These partnerships have fostered a collaborative environment that enhances innovation in their respective fields.
Conclusion
Sheng-Nan Lo's contributions to radiotherapy and cancer treatment through his innovative patents highlight his role as a leading inventor in the medical field. His work continues to pave the way for advancements in cancer diagnosis and therapy.